Skip to main content
Top
Published in: Journal of Inherited Metabolic Disease 3/2015

01-05-2015 | Editorial

Glycogen storage diseases of all types

Authors: Georg F. Hoffmann, P. A. Smit, B. Schoser

Published in: Journal of Inherited Metabolic Disease | Issue 3/2015

Login to get access

Excerpt

Defects of glycogen metabolism are among the earliest recognized inborn errors of metabolism, first described in 1928 and 1929. When Schönheimer demonstrated in 1929 that an enzyme that degrades glycogen was missing in the liver of a patient suffering from what is now known as glycogenosis type 1 or von Gierke disease, Sir Archibald Garrod’s concept that inborn errors of metabolism result from genetically determined enzyme deficiencies was proven for the first time. Since then, a multitude of disturbances of glycogen metabolism was defined, and virtually defects of all proteins involved in synthesis, transport, degradation of glycogen and its regulation have been discovered. The delineation of glycogenin-1 deficiency in 2010 marked the 20th monogenic defect in this field and was designated as glycogen storage disease type XV. …
Metadata
Title
Glycogen storage diseases of all types
Authors
Georg F. Hoffmann
P. A. Smit
B. Schoser
Publication date
01-05-2015
Publisher
Springer Netherlands
Published in
Journal of Inherited Metabolic Disease / Issue 3/2015
Print ISSN: 0141-8955
Electronic ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-015-9848-2

Other articles of this Issue 3/2015

Journal of Inherited Metabolic Disease 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.